CD44 and malignant glioma: Our experimental results suggested that M2‐like TAMs activated the PI3K/Akt/HIF‐1α/CA9 pathway in the malignant glioma cells via SPP1‐CD44‐mediated intercellular interaction to promote the recurrence of malignant glioma.